Skip to main content
  • EXTENDED RELEASE DRUG DELIVERY SYSTEM: A REVIEW

    About Authors:
    Mahek Goel*, Minakshi Marwaha
    Shri Baba Mast Nath Institute of Pharmaceutical Sciences and Research, Asthal
    Bohar, Rohtak-12400
    1
    *mahekgoel10@gmail.com

    Abstract
    Oral drug delivery system is the largest and the oldest segment of the total drug delivery market. As the drug which are presently available in the market suffered from the problem of resistance due to their irrational use as well as very few drugs are coming out of research and development, so there is need of the development of oral controlled drug delivery system (CDDS). Controlled release dosage forms are designed in such a way so that to maintain a constant level of drug for a specific period of time with minimum side effects. CDDS optimizes the biopharmaceutical, pharmacokinetic and pharmacodynamic properties in such a way that its dosing frequency is reduced to an extent that once daily administration is sufficient to maintain the desired therapeutic level of drug with reduction in side effects in shorter possible time to assure greater patient compliance. This review describes various advantages, disadvantages, types of modified release, desired characteristics, approaches and evaluation tests for controlled release dosage forms.

  • REGISTRATION DOSSIER OF PHARMACEUTICALS

    About Authors:
    Apeksha Gupta
    Maharshi Dayanand University,
    Rohtak, India.
    apekshagupta87@gmail.com

    ABSTRACT
    The word “Dossier” has its English meaning as - a collection or file of documents on the same subject, especially a file containing detailed information about a person or a topic. Any preparation for human use that is intended to modify or explore physiological systems or pathological states for the benefit of the recipient is called as “pharmaceutical product for human use”. Process of reviewing and assessing the dossier of a pharmaceutical product containing its detailed data (administrative, chemistry, pre-clinical and clinical)  and the permission granted by the Regulatory Agencies of a country with a view to support its marketing / approval in a country is called as the “Marketing Approval  or the “Registration” “Marketing Authorization” or the “Product Licensing”.
    “Registration Dossier” of the pharmaceutical product is a document that contains all the technical data (administrative, quality, nonclinical and clinical) of a pharmaceutical product to be approved / registered / marketed in a country. It is more commonly called as the New Drug Application (NDA) in the USA or Marketing Authorization Application (MAA) in the European Union (EU) and other countries, or simply Registration Dossier. Basically, this consists of data proving that the drug has quality, efficacy and safety properties suitable for the intended use, additional administrative documents, samples of finished product or related substances and reagents necessary to perform analyzes of finished product. Therefore, they are the vehicle in a country through which drug sponsors formally propose that the Regulatory Agencies approve a new pharmaceutical for sale and marketing.

    [adsense:336x280:8701650588]

  • A REVIEW ON: AEGLE MARMELOS

    About Authors:
    Kishan Singh *, Krishn Kumar Agrawal
    Institute of Pharmaceutical Research GLA University,
    Mathura-281403 (U.P.) India.
    *kishan.singh575@gmail.com

    ABSTRACT
    Herbal drugs are traditionally used in various parts of the world to cure different diseases. The Ayurvedic and Siddha medical systems are very famous medical practices in Indian traditional medicines. Over the last few ,researcher have aimed at identifying and validation plant derived substance for the treatment of various disease .similarly it has been already proved that various parts of plants such as leaf, fruits seeds etc.provide heath and nutrition promoting compounds traditional used against various disease. Aegle marmelos have been used in ethno medicine to exploit its’ medicinal properties including astringent, antidiarrheal antidysentric, demulcent, antipyretic, and anti-inflammatory activities. The present review aims to complete medicinal values of Aegle marmelos generated through the research activity using modern scientific approaches and innovative scientific tools.

  • FORMULATION AND EVALUATION OF AMOXICILLIN TRIHYDRATE MODIFIED RELEASE DOSAGE FORMS

    About Author:
    *1 Patel Dimpalben Girishkumar, 2 Mr.K.H.Shah, 3 Rohit K Patel,
    3Yatish Shukla, 3 Modi B, 3 Nilesh Patel
    1 Dharmaj Degree Pharmacy College,

    Dist- Anand, Dharmaj -388430, Gujarat
    2 Professor, IPCPRC, Dharmaj, Gujarat
    3 KAPTAB Pharmaceuticals
    *dimplepatel70@gmail.com

    Abstract
    The aim of the current investigation is to design oral once daily modified  release dosage forms of amoxicillin trihydrate for treatment of pharyngitis/tonsilitis,  which release the drug for 24 hours and match with theoretical drug release profile.  The tablets and capsules were prepared by the different method using different  polymers in different concentrations. The interference of the polymers was ruled out  by FT-IR spectroscopy studies. The powder-blends of tablets and drug were evaluated  for their physical properties like angle of repose, bulk density, compressibility  index, and Hausner ratio and found to be satisfactory. The manufactured tablets  were evaluated for in process and finished product quality control tests including  appearance, thickness, weight variation, hardness, friability, drug content, and in  vitro drug release. All formulations showed appearance, thickness, weight variation,  hardness, friability and drug content in specified limit. All formulations showed  acceptable pharmacotechnical properties and complied with in-house specifications  for tested parameters. The results of dissolution studies indicated that formulation  containing 50% ethyl cellulose and 50% methocel was the most successful  formulation which was evidenced by similarity (f2) and dissimilarity (f1) factors. The  formulated amoxicillin trihydrate tablets followed zero order release kinetics and  Higuchi diffusion was the dominant mechanism of drug release, resulting in regulated  and complete release within 24 hours. Formulations were subjected to short term  stability studies as per ICH guidelines and were found stable. Capsule formulations  16  were evaluated for weight uniformity, drug content and in vitro drug release. The  results of dissolution studies indicated that drug release from capsule not extend up to  24hrs. All formulations of capsule failed in in-vitro drug release test. In comparison of  tablet and capsule formulations, tablet found to be successful dosage form.

  • A REVIEW ON TARGETED DRUG THERAPY FOR CANCER: A NOVEL DRUG DELIVERY APPROACH

    About Author:
    Kabita Banik
    B.pharm;(WBUT) BCDA College of pharmacy &Technology;
    M.pharm(BPUT) Dadhichi college of pharmacy.
    banikkabita64@gmail.com

    Abstract:
    New cancer targeted therapies that make use therapeutic antibodies or small molecules have made treatment more tumor specific and less toxic. Nevertheless, there remain several challenges to the treatment of cancer, including drug resistance, cancer stem cells, and high tumor interstitial fluid pressure. In many solid tumors, for example, increased interstitial fluid pressure makes the uptake of therapeutic agents less efficient. One of the most promising ways of meeting such challenges is ligand-targeted therapy that may be used to make targeting more specific and carry higher dosages of anti-cancer drug to tumor tissue.

  • ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR ESTIMATION OF CLOPIDOGREL BY DERIVATIVE SPECTROSCOPY (FOURTH ORDER)

    About Authors:
    Gunjan Kalyani*, Vishal S. Deshmukh, Pranita Kashyap, Ram D. Bawankar, Yogesh Vaishnav, Deepak Biswas
    Shri Rawatpura Sarkar Institute of Pharmacy,
    Behind power grid, Kumhari, Durg, Chhattisgarh
    *kalyani.gunjan@yahoo.in

    Abstract
    Clopidogrel bisulfate is an inhibitor of adenosine diphosphate (ADP)-induced platelet aggregation acting by direct inhibition of ADP binding to its receptor and of the subsequent ADP-mediated activation of the glycoprotein GPIIb/IIIa complex. Objective of the present study is to develop a simple, sensitive, accurate, precise and rapid derivative spectrophotometric method for the estimation of clopidogrel in pure form. For the estimation of clopidogrel, solvent system employed was 0.1 N HCl and wavelength of detection (λdet) was 284.3 nm for fourth order derivative spectroscopy. The linearity was obtained in the range 42 – 336 µg/ml. The limit of detection is 6.7 µg/ml and limit of quantification was fund to be 20.4 µg/ml. Obtained results showed that there is minimum intra day and inter day variation. The developed method was validated and recovery studies were also carried out. Sample recovery using the above method was in good agreement with their respective labeled claim, thus suggesting the validity of the method and non-interference of formulation excipients in the estimation. Fourth order derivative spectroscopic method is simple, rapid and reproducible and further it can be used for the analysis.

  • ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF CANDESARTAN CILEXETIL BY CHROMATOGRAPHIC TECHNIQUE (RP-HPLC).

    About Authors:
    Gunjan Kalyani*, Vishal S. Deshmukh, Pranita Kashyap, Ram D. Bawankar, Yogesh Vaishnav, Deepak Biswas
    Shri Rawatpura Sarkar Institute of Pharmacy,
    Behind power grid, Kumhari, Durg, Chhattisgarh
    *kalyani.gunjan@yahoo.in

    Abstract:
    A simple, rapid and precise and accurate RP-HPLC method was developed for the estimation of candesartan. The method involves a simple technique using Irbesartan as internal standard. HPLC separation was achieved using C18 Intersil column (256 x 4.6 id) with an isocratic mobile phase composed of selected methanol: 10 mM Phosphate buffer [75:25 % v/v. pH 3.0] at a flow rate of 1.0 mL/min with UV detection was performed at 256 nm. The retention time of candesartan and internal standard was found to be 1.96 and 3.33 min respectively. The assay was validated for the parameters like accuracy, precision, robustness and system suitability parameters. The method was validated over a linear test concentration range of 80 - 120%. The recovery of the method was in between 99.0 - 101.0%. The proposed method was found to be accurate, precise, selective and rapid and it can be useful in the routine analysis for the determination of candesartan cilexetil in pharmaceutical dosage form.

    [adsense:336x280:8701650588]

  • HERBAL ALTERNATIVES TO ASTHMA

    Aabout Author:
    Dhirendra C. Patel*
    Master of Pharmacy, Department of Pharmaceutics and Pharmaceutical Technology,
    S.K. Patel College of Pharmaceutical Education and Research, Ganpat University,
    Kherva, Mehsana, Gujarat, India.
    dhiren.pharmacy@gmail.com

    Abstract:
    Herbal medicines are very popular in treatment of the asthma in the modern era because of lots of benefits of it like less cost, less side effects, easily available etc. Herbal alternatives to asthma are better way for treatment of asthma. Various herbal medicines recognize that immune system functioning can play a vital role in helping to control the symptoms of asthma and strengthen the body's defenses against environmental allergens. Herbal medicines like ephedra, ginger, chamomile, elderberry, licorice, mullein, stinging nettle etc are very beneficial in asthma. Scientists have found evidence to support herbal's wide range of medicinal actions. These actions include the lowering of cholesterol levels, relief for allergies and asthma etc. Herbs have been used by people for longer than we have been keeping written record. Originally they were found in the wild by the gatherers and used for lots of different things. I light here, the use of herbals in asthma. It aims to tap into the body’s own healing mechanism by transforming the “triggers” of such attacks as part of the remedy. Opinions of different authors are saying that herbal medication is better way for asthma treatment.

  • ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF SALMETEROL BY UV SPECTROSCOPY

    About Authors:
    Gunjan Kalyani*, Vishal S. Deshmukh, Pranita Kashyap, Yogesh Vaishnav, Ajit Kumar Pandey
    Shri Rawatpura Sarkar Institute of Pharmacy,
    Kumhari, Durg, Chhattisgarh.
    kalyani.gunjan@yahoo.in, rvg_54767@yahoo.co.in*

    Abstract:
    The IUPAC Name of Salmeterol is (RS)-2-(hydroxymethyl)-4-{1-hydroxy-2-[6-(4-phenylbutoxy) hexylamino]ethyl}phenol. Salmeterol is a prescription drug that is used for treating airway spasms in people with asthma or chronic obstructive pulmonary disease (COPD). By relaxing the muscles around the airways to allow more air into and out of the lungs, the medication can help prevent asthma attacks from occurring.Salmeterol comes in the form of an inhalation powder and is generally used twice a day. Present research work deals with UV spectrophotometric method for the estimation of salmeterol in pure form. For the estimation of salmeterol, solvent system employed was ethanol and wavelength of detection (λdet) was 252 nm. The linearity was obtained in the range 6 – 14 µg/ml, with a regression coefficient, R2= 0.999. The LOD & LOQ were found to be 4.99 µg/ml and 14.24 µg/ml respectively. Obtained results showed that there is minimum intra day and inter day variation. The developed method was validated and recovery studies were also carried out. Sample recovery using the above method was in good agreement with their respective labeled claims, thus suggesting the validity of the method and non-interference of formulation excipients in the estimation.

  • A REVIEW: PARENTERAL CONTROLLED DRUG DELIVERY SYSTEM

    About Author:
    Mahek Goel

    Shri Baba Mastnath Institute of Pharmaceutical Science & Research
    Asthal Bohar, Rohtak, Haryana (124001)
    mahekgoel10@gmail.com

    ABSTRACT
    Parenteral drug delivery systems are the preparations that are given other than oral route. (Para-outside, enteric–intestine). Parenteral drug delivery systems are most preferred drug delivery systems as they meet many benefits over other dosage forms in many cases such as unconsciousness, nausea, in emergency clinical episodes. The Parenteral administration route is the most common and efficient for delivery of active drug substances with poor bio-availability and the drugs with a narrow therapeutic index. But parenteral route offers rapid onset of action with rapid declines of systemic drug level. For the sake of effective treatment it is often desirable to maintain systemic drug levels within the therapeutically effective concentration range for as long as treatment calls for. It requires frequent injection, which ultimately leads to patient discomfort. For this reason, drug delivery system which can reduce total number of injection throughout the effective treatment, improve patient compliance as well as pharmacoeconomic. These biodegradable injectable drug delivery system offer attractive opportunities for protein delivery and could possibly extend patent life of protein drugs.Parenteral drug delivery system seeks to optimize therapeutic index by providing immediate drug to the systemic pool in required quantity to treat– cardiac attacks, respiratory attacks. This article explores various prolonged release parenteral drug delivery system and their strategies of preparation, their potential benefits/drawbacks and in-vitro testing methods.

Subscribe to Articles